Hong Kong Renewable Energy Stock News

NetEase Cloud Music (SEHK:9899) reported a noteworthy financial turnaround with its recent earnings release, showcasing a significant rise in net income and earnings per share, despite a decline in sales from the previous year. These developments may have added weight to the company's 18% price increase last quarter amid a robust market environment with the S&P 500 and Nasdaq hitting all-time highs. The half-year results reflect operational efficiencies and effective cost management...

Pop Mart International Group (SEHK:9992) saw its shares rise by 3.15% over the last quarter, a period marked by key developments like its inclusion in both the Hang Seng Index and the Hang Seng China Enterprises Index on September 8, 2025. This addition underscores the company's growing prominence following impressive financial results reported on August 19, 2025, which showed significant year-over-year gains in sales and net income. During this time, major indices like the S&P 500 and Nasdaq...

Akeso (SEHK:9926) recently captured attention by presenting promising data on its cadonilimab therapy at the World Conference on Lung Cancer, highlighting its potential as a breakthrough treatment for immunotherapy-resistant non-small cell lung cancer. Over the last quarter, the company's share price surged 40%, potentially influenced by these significant clinical developments and the awarding of Breakthrough Therapy Designation. The broader market trend, which saw indices like the S&P 500...

Alphamab Oncology (SEHK:9966) recently reported favorable earnings for the half year ended June 2025, showcasing a revenue increase to CNY 319 million and a net income turnaround to CNY 21 million from a prior loss. This aligns well with their earlier guidance that anticipated a profit shift, bolstered by milestones from licensed collaborations. Amid these events, the company's stock rose 31% in the last quarter. The positive trajectory might have been bolstered by the overall robust market...

Ascletis Pharma (SEHK:1672) recently announced noteworthy advancements related to its investigational drug ASC30, showcasing a promising 75-day half-life in a clinical study, which propelled excitement around potential once-quarterly administration for obesity management. As a result, the company's share price increased by nearly 48% over the last quarter. This rise occurred against a backdrop of broader market gains, with indexes like the Nasdaq and S&P 500 reaching all-time highs,...

Star Shine Holdings Group (SEHK:1440) recently saw a stock price increase of 40% over the last quarter, coinciding with its entry into the intellectual property sector through a strategic partnership and an exhibition based on Japanese animation "One Piece" in China. Additionally, the company expanded its youth sports initiatives by entering a sub-license agreement to operate the Paris Saint-Germain Academy in Hong Kong and Macau. Despite announcing increased losses due to external pressures...

Innovent Biologics (SEHK:1801) has recently been part of a significant client announcement, with a new partnership with Fangzhou Inc. aimed at integrating digital health services into innovative therapies for metabolic diseases. This event coincided with the company's share price rising 23% over the last quarter. Aside from this strategic move, the company has also witnessed FDA approval for key investigational drugs such as IBI363, adding weight to its impressive price performance. However,...

Mongolian Mining (SEHK:975) recently announced first-half 2025 earnings, revealing a sales decrease to USD 346.65 million and a net loss of USD 23.32 million. Despite these challenges, the company's share price rose significantly by 54% over the last quarter. While their financial results showed declines, broader market trends, such as record highs in major indices like the S&P 500 and Nasdaq, likely supported this price move. Additionally, emerging investor interests in commodity stocks,...

Tianneng Power International (SEHK:819) recently reported a notable decline in sales and net income for the first half of 2025, with sales dropping to CNY 24,192 million from CNY 49,915 million the previous year. Despite this, the company's share price rose 30% over the last quarter, a movement that coincides with the broader market trends where key indices like the S&P 500 and Nasdaq reached all-time highs. While the market's bullish sentiment may have buffered Tianneng's financial results,...

On September 9, 2025, Sinotrans (SEHK:598) held a board meeting to discuss potential changes to its Articles of Association, a precursor to proposals set to be presented at a forthcoming Extraordinary General Meeting. During the last quarter, Sinotrans's share price rose by approximately 23%, coinciding with these governance discussions and the announcement of an interim dividend. Although Sinotrans's recent earnings displayed slight income growth, the company's market performance largely...

Harbin Electric (SEHK:1133) recently experienced a 63% increase in share price over the last quarter. This growth can be linked to a series of strategic events, including a robust earnings report on August 28, 2025, revealing significant increases in sales and net income compared to the previous year. The appointment of Mr. Liu Qing-yong as executive director and Chairman of the Strategy Development Committee may have also influenced market perceptions positively. While the broader market,...

Following the recent announcements, Yunfeng Financial Group (SEHK:376) has seen a substantial share price surge of 108% over the past month. The company's impressive earnings announcement on August 28, 2025, which reported a substantial increase in net income to HKD 486 million from HKD 201 million, aligns with market enthusiasm that contributed to the broader market uptrend. Additionally, the new strategic partnership with Ant Digital Technologies and the investment in Pharos Network...

China Travel International Investment Hong Kong (SEHK:308) recently experienced a 56% share price increase over the last quarter, a movement occurring despite challenging financial results for the first half of 2025. The company's sales declined to HKD 1,974 million from HKD 2,137 million the previous year, coupled with a net loss of HKD 87 million. During this period, the overall market saw exponential gains, driven by sectors unrelated to the company's core operations. This price adjustment...

New World Development (SEHK:17) experienced a significant price surge of 66% over the last quarter, likely influenced by its recent strategic discussions to potentially sell its flagship 11 Skies mall for between HKD 15 billion (USD 1.9 billion) amid liquidity pressures. Additionally, the resignation of Dr. Cheng Chi-Kong, Adrian, as a non-executive director may have added to the volatility. These developments occurred alongside broader market trends, where the S&P 500 and Nasdaq set all-time...

Great Eagle Holdings (SEHK:41) probably stands out on your watchlist if you’ve noticed its recent stock performance. While there’s no specific headline driving today’s move, the steady uptick in share price might still prompt investors to ask if something deeper is at play, especially in a market that is often quick to react to subtle changes. Sometimes, the absence of a clear event can spark even more curiosity around a stock’s underlying value and what the market might be sensing in...

Has China Overseas Land & Investment (SEHK:688) Quietly Turned a Corner? If you follow China Overseas Land & Investment (SEHK:688), you might have noticed the stock gaining steady ground lately, even in the absence of any headline-making announcements. That sort of move can leave investors scratching their heads, wondering if it’s a passing trend or a genuine signal that the company is gathering momentum. Sometimes, when the news feed is quiet, the shift is all about changing market sentiment...

Recent Moves Bring Deep Source Holdings (SEHK:990) Into Focus Deep Source Holdings (SEHK:990) has caught the eye of investors once again, even without any single headline-grabbing event pushing it into the spotlight. Sometimes, a stock’s movement or lack thereof speaks volumes, prompting questions about where it is headed and whether there is an opportunity developing beneath the surface. Right now, the conversation around Deep Source is less about flashy news and more about deciphering what...

Power Assets Holdings (SEHK:6) may not have made headlines with a major announcement this week, but its share price movement has caught the attention of a number of investors wondering if something more could be at play. With the stock edging slightly lower over the past month, it has prompted some to take a closer look at what is driving sentiment, and what that might mean for future prospects. Sometimes a pause like this sparks as many questions as a sudden rally or drop. From a broader...

Meituan (SEHK:3690) has just released its latest earnings report, and if you’re keeping an eye on the stock, you’re not alone. The update delivered a classic push-pull for investors: sales in the second quarter jumped compared to last year, but net income tumbled, raising new questions about how the company is balancing growth with profitability. This mix of sales strength and weaker bottom-line results is putting Meituan squarely in the spotlight as investors try to figure out if the company...

Most readers would already be aware that BioDlink International's (HKG:1875) stock increased significantly by 18% over...

Key Insights Nongfu Spring's significant insider ownership suggests inherent interests in company's expansion 84% of...

As global markets navigate a complex landscape of fluctuating interest rates and economic signals, investors are increasingly exploring diverse opportunities across various sectors. Penny stocks, often associated with smaller or newer companies, continue to capture attention for their potential to offer growth opportunities despite the term being somewhat outdated. By focusing on financial strength and long-term potential, these stocks can present attractive prospects for those looking to...

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

Key Insights The projected fair value for CSPC Pharmaceutical Group is HK$16.41 based on 2 Stage Free Cash Flow to...